Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules

Epithelial-mesenchymal transition (EMT) enables epithelial cells to acquire motility and invasiveness that are characteristic of mesenchymal cells. It plays an important role in development and tumor cell metastasis. However, the mechanisms of EMT and their dysfunction in cancer cells are still not...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 108; no. 31; pp. 12851 - 12856
Main Authors Li, Nan, Jiang, Peng, Du, Wenjing, Wu, Zhengsheng, Li, Cong, Qiao, Mengran, Yang, Xiaolu, Wu, Mian
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 02.08.2011
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Epithelial-mesenchymal transition (EMT) enables epithelial cells to acquire motility and invasiveness that are characteristic of mesenchymal cells. It plays an important role in development and tumor cell metastasis. However, the mechanisms of EMT and their dysfunction in cancer cells are still not well understood. Here we report that Siva1 interacts with stathmin, a microtubule destabilizer. Siva1 inhibits stathmin's activity directly as well as indirectly through Ca²⁺/calmodulin-dependent protein kinase II-mediated phosphorylation of stathmin at Ser16. Via the inhibition of stathmin, Siva1 enhances the formation of microtubules and impedes focal adhesion assembly, cell migration, and EMT. Low levels of Siva1 and Ser16-phosphorylated stathmin correlate with high metastatic states of human breast cancer cells. In mouse models, knockdown of Siva1 promotes cancer dissemination, whereas overexpression of Siva1 inhibits it. These results suggest that microtubule dynamics are critical for EMT. Furthermore, they reveal an important role for Siva1 in suppressing cell migration and EMT and indicate that down-regulation of Siva1 may contribute to tumor cell metastasis.
Bibliography:http://dx.doi.org/10.1073/pnas.1017372108
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Author contributions: N.L., P.J., W.D., X.Y., and M.W. designed research; N.L., P.J., W.D., Z.W., C.L., and M.Q. performed research; N.L., P.J., W.D., X.Y., and M.W. analyzed data; and N.L., X.Y., and M.W. wrote the paper.
Edited by Joan S. Brugge, Harvard Medical School, Boston, MA, and approved June 20, 2011 (received for review November 19, 2010)
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1017372108